These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 14974743

  • 21. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM, Blank R, Smith Fawzi MC, Bayona J, Becerra MC, Mitnick CD.
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [Abstract] [Full Text] [Related]

  • 22. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W.
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [Abstract] [Full Text] [Related]

  • 23. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
    Mendoza MT, Gonzaga AJ, Roa C, Velmonte MA, Jorge M, Montoya JC, Tan Torres T, Ong M, Barez MY, Ang CF.
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens.
    Van Deun A, Aung KJ, Chowdhury S, Saha S, Pankaj A, Ashraf A, Rigouts L, Fissette K, Portaels F.
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):143-8. PubMed ID: 10091880
    [Abstract] [Full Text] [Related]

  • 27. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.
    Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E.
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):332-7. PubMed ID: 18284841
    [Abstract] [Full Text] [Related]

  • 28. Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India.
    Santha T, Thomas A, Chandrasekaran V, Selvakumar N, Gopi PG, Subramani R, Rajeswari R, Rani B, Paramasivan CN, Perumal M, Wares F, Narayanan PR.
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):52-7. PubMed ID: 16466037
    [Abstract] [Full Text] [Related]

  • 29. Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
    Riantawan P, Punnotok J, Chaisuksuwan R, Pransujarit V.
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):616-20. PubMed ID: 9712274
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rüsch-Gerdes S, Blok L, Doshetov D.
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [Abstract] [Full Text] [Related]

  • 32. Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis.
    Lockman S, Kruuner A, Binkin N, Levina K, Wang Y, Danilovitsh M, Hoffner S, Tappero J.
    Clin Infect Dis; 2001 Feb 01; 32(3):373-80. PubMed ID: 11170944
    [Abstract] [Full Text] [Related]

  • 33. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L, Zheng SH, Chu NH, Xie YG, Yang YZ, Li Q, Wang XM, Yan XL, Tan WG, Miao ZP, Duanmu HJ.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3387-91. PubMed ID: 19159566
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D, Seyoum B, Makonnen E, Atsebeha H, Woldemeskel D, Yamuah L, Addus H, Aseffa A.
    Ethiop Med J; 2008 Oct 30; 46(4):367-74. PubMed ID: 19271401
    [Abstract] [Full Text] [Related]

  • 36. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
    Tudó G, González J, Obama R, Rodríguez JM, Franco JR, Espasa M, Simarro PR, Escaramís G, Ascaso C, García A, Jiménez de Anta MT.
    Int J Tuberc Lung Dis; 2004 Jan 30; 8(1):15-22. PubMed ID: 14974741
    [Abstract] [Full Text] [Related]

  • 37. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2001 Sep 30; 5(9):815-23. PubMed ID: 11573892
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
    Angarano G, Carbonara S, Costa D, Gori A.
    Int J Tuberc Lung Dis; 1998 Apr 30; 2(4):303-11. PubMed ID: 9559401
    [Abstract] [Full Text] [Related]

  • 40. [Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan].
    Kazumi Y, Itagaki N, Ohmori M, Wada M, Hoshino H, Mitarai S, Sugawara I, Ishikawa N, Mori T.
    Kekkaku; 2007 Dec 30; 82(12):891-6. PubMed ID: 18188977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.